Pre-participation screening of asymptomatic athletes: “Don’t do stupid stuff”

por Mosterd, A.
Publicado 2018

Targeting residual inflammatory risk in coronary disease: to catch a monkey by its tail

por Fiolet, A. T. L., Opstal, T. S. J., Silvis, M. J. M., Cornel, J. H., Mosterd, A.
Publicado 2021

Age- and gender-specific risk of death after first hospitalization for heart failure

por Vaartjes, I, Hoes, AW, Reitsma, JB, de Bruin, A, Grobbee, DE, Mosterd, A, Bots, ML
Publicado 2010

Training general practitioners to improve evidence-based drug treatment of patients with heart failure: a cluster randomised controlled trial

por Valk, M. J. M., Hoes, A. W., Mosterd, A., Landman, M. A., Zuithoff, N. P. A., Broekhuizen, B. D. L., Rutten, F. H.
Publicado 2020

Sodium-glucose cotransporter 2 inhibitors: a practical guide for the Dutch cardiologist based on real-world experience

por Zwart, K., Velthuis, S., Polyukhovych, Y. V., Mosterd, A., Smidt, L., Serné, E. H., van Raalte, D. H., Elders, P. J. M., Handoko, M. L., Oldenburg-Ligtenberg, P. C.
Publicado 2021

Nationwide claims data validated for quality assessments in acute myocardial infarction in the Netherlands

por Eindhoven, D. C., van Staveren, L. N., van Erkelens, J. A., Ikkersheim, D. E., Cannegieter, S. C., Umans, V. A. W. M., Mosterd, A., van Wijngaarden, J., Schalij, M. J., Borleffs, C. J. W.
Publicado 2017

No psychological distress in sportsmen aged 45 years and older after cardiovascular screening, including cardiac CT: The Measuring Athlete’s Risk of Cardiovascular events (MARC) st...

por Schurink, M. M., Braber, T. L., Prakken, N. H. J., Doevendans, P. A. F. M., Backx, F. J. G., Grobbee, D. E., Rienks, R., Nathoe, H. M., Bots, M. L., Velthuis, B. K., Mosterd, A.
Publicado 2017

Rationale and design of the Measuring Athlete’s Risk of Cardiovascular events (MARC) study: The role of coronary CT in the cardiovascular evaluation of middle-aged sportsmen

por Braber, T. L., Mosterd, A., Prakken, N. H. J., Doevendans, P. A. F. M., Mali, W. P. Th. M., Backx, F. J. G., Grobbee, D. E., Rienks, R., Nathoe, H. M., Bots, M. L., Velthuis, B. K.
Publicado 2014

Plasma extracellular vesicle protein content for diagnosis and prognosis of global cardiovascular disease

por Wang, J. W., Gijsberts, C. M., Seneviratna, A., de Hoog, V. C., Vrijenhoek, J. E. P., Schoneveld, A. H., Chan, M. Y., Lam, C. S. P., Richards, A. M., Lee, C. N., Mosterd, A., Sze, S. K., Timmers, L., Lim, S. K., Pasterkamp, G., de Kleijn, D. P. V.
Publicado 2013

Plasma extracellular vesicle proteins are associated with stress-induced myocardial ischemia in women presenting with chest pain

por Dekker, Mirthe, Waissi, Farahnaz, van Bennekom, Joelle, Silvis, Max J. M., Timmerman, Nathalie, Bank, Ingrid E. M., Walter, Joan E., Mueller, Christian, Schoneveld, A. H., Schiffelers, Raymond M., Pasterkamp, Gerard, Grobbee, Diederick E., de Winter, Robbert J., Mosterd, A., de Kleijn, Dominique P. V., Timmers, Leo
Publicado 2020

The challenge of choosing in cardiovascular risk management

por Hoogeveen, R. M., Hanssen, N. M. J., Brouwer, J. R., Mosterd, A., Tack, C. J., Kroon, A. A., de Borst, G. J., ten Berg, J., van Trier, T., van Lennep, J. Roeters, Liem, A., Serné, E., Visseren, F. L. J., Cornel, J. H., Peters, R. J. G., Jukema, J. W., Stroes, E. S. G.
Publicado 2021

A randomised comparison of the effect of haemodynamic monitoring with CardioMEMS in addition to standard care on quality of life and hospitalisations in patients with chronic heart...

por Brugts, J. J., Veenis, J. F., Radhoe, S. P., Linssen, G. C. M., van Gent, M., Borleffs, C. J. W., van Ramshorst, J., van Pol, P., Tukkie, R., Spee, R. F., Emans, M. E., Kok, W., van Halm, V., Handoko, L., Beeres, S. L. M. A., Post, M. C., Boersma, E., Lenzen, M. J., Manintveld, O. C., Koffijberg, H., van Baal, P., Versteegh, M., Smilde, T. D., van Heerebeek, L., Rienstra, M., Mosterd, A., Delnoy, P. P. H., Asselbergs, F. W., Brunner-La Rocca, H. P., de Boer, R. A.
Publicado 2019